New sites expected to further accelerate patient enrollment, which surpassed 50% in Phase III study, as well as support ...
AgomAb Therapeutics NV ( AGMB) has filed to raise $200 million in development capital in an IPO of its American Depositary Shares representing underlying common shares, according to SEC F-1/A ...
Stay informed on Burn Research advancements at Hamilton Health Sciences and their innovative trial for better burn recovery ...
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
The Evidence to Recommendations framework ensured that the US vaccine schedule was scientifically sound. Then RFK Jr. abandoned it ...
SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
CANTANHEDE, PORTUGAL, NEW YORK CITY, USA AND DUBLIN, IRELAND, January 12, 2026 /EINPresswire.com/ -- • An early-phase ...
Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical ...
Fecal microbiota transplants (FMT) can dramatically improve cancer treatment, suggest two groundbreaking studies published in ...
Worldwide Clinical Trials, a full-service, global CRO headquartered in Research Triangle Park, has entered into a definitive agreement to acquire Wilmington-based Catalyst Clinical Research, a global ...
Cynata Therapeutics, Racura Oncology and Dimerix are among ASX health companies reporting milestones reached in quarterly ...
A new study has shown for the first time that an experimental vaccine against Middle East Respiratory Syndrome (MERS) induces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results